1. Home
  2. SCLX vs BDL Comparison

SCLX vs BDL Comparison

Compare SCLX & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.57

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$31.00

Market Cap

62.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
BDL
Founded
2011
1959
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
62.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SCLX
BDL
Price
$6.57
$31.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.1K
895.0
Earning Date
05-13-2026
02-10-2026
Dividend Yield
N/A
1.76%
EPS Growth
N/A
49.72
EPS
N/A
0.43
Revenue
N/A
$205,248,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
$72.56
Revenue Growth
N/A
8.99
52 Week Low
$0.18
$22.61
52 Week High
$34.27
$35.98

Technical Indicators

Market Signals
Indicator
SCLX
BDL
Relative Strength Index (RSI) 30.61 43.77
Support Level $4.56 $29.56
Resistance Level $7.50 $33.12
Average True Range (ATR) 0.64 0.61
MACD -0.13 -0.35
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SCLX
BDL

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: